Literature DB >> 6283616

Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).

G Utermann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283616

Source DB:  PubMed          Journal:  Ric Clin Lab        ISSN: 0390-5748


× No keyword cloud information.
  5 in total

1.  Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.

Authors:  S C Rall; Y M Newhouse; H R Clarke; K H Weisgraber; B J McCarthy; R W Mahley; T P Bersot
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

2.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.

Authors:  K H Weisgraber; S C Rall; T L Innerarity; R W Mahley; T Kuusi; C Ehnholm
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

3.  Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.

Authors:  P de Knijff; A M van den Maagdenberg; A F Stalenhoef; J A Leuven; P N Demacker; L P Kuyt; R R Frants; L M Havekes
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

4.  Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.

Authors:  S C Rall; K H Weisgraber; T L Innerarity; T P Bersot; R W Mahley; C B Blum
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease.

Authors:  Ana-Caroline Raulin; Lucas Kraft; Youssra K Al-Hilaly; Wei-Feng Xue; John E McGeehan; John R Atack; Louise Serpell
Journal:  J Mol Biol       Date:  2019-04-30       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.